Authors
Latest:
Key Observations on GDPRAs we pass the 6-month anniversary of theGeneral Data Protection Regulation's effective date, the number of organizations which boast 100% GDPR compliance has certainly increased. But life sciences companies are still grappling with implementation of the policy and procedure changes, writes Ashley Williams.
Latest:
Identity Crisis: Data Protection Roles for Life Sciences CompaniesJames Clark addresses one of the key questions data protection and compliance officers are asking following the implementation of the General Data Protection Regulation -"What role am I playing under the GDPR?"
Latest:
Finding the Right Digital Health PartnerPharma companies are increasingly expanding their portfolios into digital health solutions. To find the right partners, there are several key considerations that inform their evaluation and selection.
Latest:
Confronting a Challenging Macroeconomic Environment with InnovationWebinar Date/Time: Thu, Mar 16, 2023 11:00 AM EDT
Latest:
Fuel Growth Through Innovative Talent StrategiesJohn Ebeid outlines talent strategies to reduce an organization's labor costs and increase quality.
Latest:
Global Health: The Need for ConsensusYou can’t make progress without consensus. This holds true for Brexit and for the unparalleled opportunity that the WHO Roadmap report on Access to Medicines and Vaccines presents, writes IFPMA's Greg Perry.
Latest:
Precision Financing of Durable, Potentially Curative TherapiesWhile gene therapies and cellular treatments are a boon for patients, they can be a financial bane for payers. Jane Barlow, Russell Teagarden, and Mark Trusheim outline alternative financing approaches, customizable for each payer’s needs and for each therapy’s characteristics.
Latest:
Engaging with Oncology Providers in a Virtual World*** Live: Thursday, Oct. 29, 2020 at 2pm EDT | 1pm CDT | 11am PDT*** E Get a behind the scenes look into the community oncology provider world through the COVID-19 emergence. Understand provider education needs and preferences and formulate effective strategies to deliver education most adapted to their needs in a virtual world. ***On demand available after final airing until Oct. 29, 2021***
Latest:
When to Utilize Commercial OutsourcingWhen deciding on the right commercialization model, organizations must consider multiple factors, including the asset or platform they possess, the launch timing, the funding required, and staffing expertise.
Latest:
Op-Ed: Opening the Golden DoorThe talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.
Latest:
From PI to Payer to Patient: RWE From the Perspective of Each Key StakeholderHow real-world evidence creates shared value for stakeholders across the healthcare spectrum.
Latest:
Easing the Path to ProfitabilitySteps for startups in tapping non-dilutive financing options.
Latest:
Maximizing the Chance of Launch Success with Orphan DrugsIn preparing to launch a rare-disease medication, it is important to understand the needs in the therapy area and invest strategically to maximize the impact on the unique rare-disease environment.
Latest:
Real-Time Information across the Pharma Supply ChainTim Willis and Oliver Wack outline the role of alternative data in supply chain risk management, and the ancillary benefits that come from adopting such technology.
Latest:
What the Purdue Pharma Case Teaches Us About Reputational TornadoesPurdue Pharma and its corporate leadership featured prominently in the media recently as litigation mounts over their sales and marketing of Oxycontin. Nir Kossovsky offers some observations about the lessons this situation provides for all corporate leaders responsible for their companies’ reputations.
Latest:
The Implications of Connected Medical Devices & Digital HealthcareLoetitia Jabri considers the broader implications as healthcare providers embraces new digital connectivity options as part of the Medicine 2.0 era.
Latest:
The Patient Comes First with Outcomes-Based ContractingThe benefits and challenges of outcomes-based contracting.
Latest:
AI Is Disrupting Higher Education: Why Even Valedictorians Must Rethink Their Career Playbooks to Stay CompetitiveA Harvard Business School Healthcare Alumni Q&A with Professor Eric Mazur of Harvard University.
